Part 12: Resuscitation Education Science: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

Appendix 1. Writing Group Disclosures

Appendix 1. Writing Group Disclosures
Writing Group Member	Employment	Research Grant	Other Research Support	Speakers' Bureau/ Honoraria	Expert Witness	Ownership Interest	Consultant/ Advisory Board	Other
Aaron Donoghue	The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine	Nihon Kohden America*	None	None	None	None	None	None
Katie N. Dainty	North York General Hospital	AMS Healthcare†	None	None	None	None	None	None
Marc Auerbach	Yale University	Toyota WayForward Foundation; EMSC; HRSA-PPN*	None	None	None	None	None	None
Arna Banerjee	Vanderbilt University Medical Center	AHRQ*	ASA*	None	None	None	None	None
AudreyBlewer	Duke University	NIH NHLBI†; NIH BIRCWH Scholar†; Laerdal Foundation †; NIH NIMHD†; AHA †	None	None	None	None	None	None
Adam Cheng	Alberta Children's Hospital (Canada)	Alberta Innovates†; HUG Foundation†; Swiss National Foundation†	None	None	None	None	None	None
Kelly Kadlec	Children's Hospital and Medical Center	None	None	None	None	None	None	None
Yiqun Lin	University of Calgary (Canada)	None	None	None	None	None	None	None
Emily Diederich	University of Kansas Medical Center	None	None	None	None	None	None	None
Taylor Sawyer	Seattle Children's Hospital/University of Washington	None	None	None	Gideon Essary Tardio Carter PLC *	None	Verathon Inc.*	None
Devita Stallings	Saint Louis University	None	None	None	None	None	None	None
Lorrel Toft	University of Nevada Reno	None	None	None	None	CardiacSTAR, LLC; Coram Technolo-gies	None	None
Deborah Torman	OhioHealth	None	None	None	None	None	None	None
Jaylen I. Wright	American Heart Association	None	None	None	None	None	None	None
Stephen Schexnayder	University of Arkansas/ Arkansas Children's Hospital	None	None	None	None	None	American Heart Association†	None

This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5,000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5,000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.

†Significant.